Revolutionizing CT Scan: The Photon-Counting Leap

Computed tomography (CT) was nothing short of revolutionary when it  came out in the early 1970s. For the first time, physicians were able to  visualize not just bones but also tumors, infections, and delicate soft tissues in remarkable detail. This discovery revolutionized diagnosis and opened the door for innumerable improvements in medical care.

Although CT scanners have advanced in speed and sophistication over the years, their core technology has stayed essentially the same. Ceramic scintillation detectors, which absorb X-rays and transform them into light that is subsequently converted into electrical signals, are still used in the majority of CT scans nowadays. This light-conversion phase in between is fundamentally inefficient. Physical barriers are required to prevent overlapping signals since light scatters in numerous directions, which lowers the detector's effectiveness. Plus, conventional detectors struggle to distinguish between a single high-energy X-ray and numerous low-energy ones. This makes it harder to spot subtle differences in soft tissues, sometimes leaving radiologists searching for crucial details.

To overcome these constraints, the photon-counting computed tomography (PCCT) was created. PCCT employs sophisticated semiconductor detectors that convert incoming X-rays straight into electrical signals rather than light. By eliminating the inefficiencies of light conversion, PCCT creates crisper images, boosts contrast, and provides extensive spectral information about how various tissues absorb X-rays, data that conventional CT systems cannot deliver. The upshot is more precise diagnostics, reduced radiation doses, and the potential to unleash new applications in diverse industries.

A Race to Reinvent CT

The development of photon-counting computed tomography (PCCT) has been influenced by years of technological challenges and innovations. Several medical imaging manufactures ventured into the development of PCCT systems over time. The first one among them is GE Healthcare. In 2008, GE Healthcare introduced an experimental scanner with cadmium-telluride (CdTe) detectors. Although there was early promise in the concept, the prototype had trouble delivering radiation levels low enough for therapeutic usage without risk. 

After six years, Siemens unveiled its own prototype, the dual-source SOMATOM CounT. With its ultra-fine subpixels and quick scan periods, the system impressed researchers by producing remarkably clear images in early patient tests and phantom models. By 2017, Philips introduced their own prototype which is a single-source PCD-CT prototype built using cadmium-zinc-telluride (CZT) detectors. Refined for human trials, their system showed potential in specialized applications such as cardiac imaging.

In 2020, Siemens returned with a second-generation prototype, the SOMATOM CounT Plus. Offering improved detector resolution and a larger field of view, this version paved the way for broader clinical testing and brought PCCT technology closer to routine medical use. Then, in 2021, Siemens finally crossed the finish line with the launch of the NAEOTOM Alpha, the world’s first commercially available PCCT scanner. Equipped with dual high-resolution CdTe detectors and multiple energy thresholds, the system set a new benchmark for temporal and spatial resolution. Early clinical studies confirmed its ability to enhance diagnostic accuracy, reduce artifacts, and lower radiation doses across a range of applications from oncology to cardiology.

Clinical Applications

Photon-Counting CT (PCCT) is shown to have distinct advantages over traditional CT technology in a variety of medical areas. By using tin filtration, it reduces radiation dosages by up to 85% while revealing the complex inner ear anatomy with amazing clarity in ear and skull imaging. It also provides incredibly crisp images of bones and joints in musculoskeletal imaging, allowing medical professionals to identify diseases and fractures that could otherwise go undetected.

Aside from that, PCCT addresses a long-standing issue for cardiologists: calcium "blooming" abnormalities, which are bright patches that frequently mask blood artery obstructions. The PCCT makes it possible to evaluate coronary arteries and stents more clearly by reducing these artifacts. Significant advantages are also being experienced by pulmonary specialists. The technology makes it easier to see ground-glass opacities and tiny airways, which are very important. 

A New Era in Medical Imaging

The photon-counting CT signifies a significant change in the medical imaging field. It has the potential to transform how diseases are detected, monitored, and treated. A new era of safer, more informative imaging is anticipated as the technology transitions from specialized clinical trials to wider use, promising to give medical practitioners more accurate tools for precise diagnosis.

References

Flohr, T., & Schmidt, B. (2023). Technical Basics and Clinical Benefits of Photon-Counting CT. Investigative Radiology, Publish Ahead of Print. https://doi.org/10.1097/rli.0000000000000980

Grove, E. (2021). With photon-counting-detector CT, Mayo Clinic at forefront of CT imaging technology - Mayo Clinic News Network. Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/discussion/with-photon-counting-detector-ct-mayo-clinic-at-forefront-of-ct-imaging-technology/

McCollough, C. H., & Rajiah, P. (2023). Milestones in CT: Past, Present, and Future. Radiology, 309(1). https://doi.org/10.1148/radiol.230803

Siemens Healthineers. (2025). Photon-counting CT – Siemens Healthineers. Siemens-Healthineers.com. https://www.siemens-healthineers.com/en-ph/computed-tomography/ct-technologies-and-innovations/photon-counting-ct

Springer Nature. (n.d.). The future of CT scans is clearer thanks to new tech. Www.nature.com. https://www.nature.com/articles/d42473-023-00450-9